Evaluation of Combination Treatment Benefits of nab-Paclitaxel in Experimental Pancreatic Cancer

被引：0
|
作者：
Awasthi, N. [1 ]
Ostapoff, K. T. [1 ]
Zhang, C. [1 ]
Schwarz, M. A. [1 ]
Schwarz, R. E. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S153 / S153
页数：1
相关论文
共 50 条
  • [31] Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
    Von Hoff, Daniel D.
    Ervin, Thomas
    Arena, Francis P.
    Chiorean, E. Gabriela
    Infante, Jeffrey
    Moore, Malcolm
    Seay, Thomas
    Tjulandin, Sergei A.
    Ma, Wen Wee
    Saleh, Mansoor N.
    Harris, Marion
    Reni, Michele
    Dowden, Scot
    Laheru, Daniel
    Bahary, Nathan
    Ramanathan, Ramesh K.
    Tabernero, Josep
    Hidalgo, Manuel
    Goldstein, David
    Van Cutsem, Eric
    Wei, Xinyu
    Iglesias, Jose
    Renschler, Markus F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18): : 1691 - 1703
  • [32] A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer
    Osman, M. A. M.
    McDermott, R.
    Fennelly, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
    Cullis, Jane
    Siolas, Despina
    Avanzi, Antonina
    Barui, Sugata
    Maitra, Anirban
    Bar-Sagi, Dafna
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03) : 182 - 190
  • [34] Effect of Preoperative Nab-paclitaxel and Gemcitabine on Pancreatic Cancer Stroma
    Ishido, K.
    Kimura, N.
    Wakiya, T.
    Nagase, H.
    Odagiri, T.
    Mitsuhashi, Y.
    Goto, S.
    Yoshizawa, T.
    Kijima, H.
    Hakamada, K.
    PANCREAS, 2019, 48 (10) : 1451 - 1451
  • [35] Phase I trial of enzalutamide in combination with gemcitabine and nab-paclitaxel in the management of advanced pancreatic cancer
    Kommalapati, A.
    Kim, R.
    Harsha, T. Sri
    Bertels, B.
    Wapinsky, G.
    Burke, N.
    Neuger, A.
    Springett, G.
    Almhanna, K.
    Mahipal, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E135 - E135
  • [36] Histopathological Changes of Pancreatic Cancer Stroma Induced by nab-Paclitaxel
    Ishido, K.
    Kudo, D.
    Kimura, N.
    Wakiya, T.
    Hakamada, K.
    PANCREAS, 2018, 47 (10) : 1395 - 1395
  • [37] Combination treatment of orexin-A and NAB-paclitaxel in pancreas cancer: in vitro and in vivo studies
    Voisin, Thierry
    Plaut, Dina
    Dayot, Stephanie
    Bergere, Maxime
    Gratio, Valerie
    Nicole, Pascal
    Couvelard, Anne
    Couvineau, Alain
    CANCER RESEARCH, 2016, 76
  • [38] Triptolide in Combination with Low Dose Gemcitabine and Nab-Paclitaxel: A Novel Effective Combination Chemotherapy Regimen for Pancreatic Cancer
    Modi, Shrey
    Giri, Bhuwan
    Garg, Bharti
    George, John
    Sethi, Vrishketan
    Banerjee, Sulagna
    Dudeja, Vikas
    Saluja, Ashok
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (04) : E49 - E49
  • [39] A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
    Chapa-Gonzalez, Christian
    Lopez, Karina
    Michelle Lomeli, Kimberly
    Alberto Roacho-Perez, Jorge
    Stevens, Jazmin Cristina
    LIFE-BASEL, 2022, 12 (03):
  • [40] Maintenance treatment with gemcitabine after gemcitabine plus Nab-paclitaxel in advanced pancreatic cancer
    Kodama, Tomoko
    Nakazawa, Junichi
    Kawahira, Masahiro
    Ymasuji, Akihiro
    Iwashita, Yuji
    Hori, Takeshi
    Kawahira, Machiko
    Arima, Shiho
    Tubouchi, Hirohito
    Ido, Akio
    ANNALS OF ONCOLOGY, 2022, 33 : S484 - S484
12345